Jon Grabenstatter

Jon Grabenstatter is an experienced professional in the biotechnology and life sciences fields, currently serving as Director of External Innovations at BioNTech SE since February 2023. Prior to this role, Grabenstatter held various leadership positions at Senda Biosciences, including Director of Protein Therapeutics and Director and Head of Metabolic Programs, where responsibilities included developing a portfolio of small molecules for metabolic health applications. Earlier experience includes consulting at Arthur D. Little, providing strategic insights for healthcare clients, and serving as a Graduate Research Associate at the Massachusetts Institute of Technology, focusing on protein biochemistry. Grabenstatter began a career in finance as an Analyst at RBC Capital Markets. Educational qualifications include a Ph.D. in Biochemistry from the Massachusetts Institute of Technology, a Master's Degree in Pathology from The Ohio State University, and a Bachelor's Degree in Microbiology from Miami University.